Education
About Us
Working with TipRanks
Follow Us
LBT Innovations Limited (AU:CC5)
ASX:CC5
CC5 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.03
Previous CloseN/A
Volume1.22M
Average Volume (3M)1.05M
Market Cap
AU$37.10M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)4.29M
Price to Earnings (P/E)―
Beta-0.91
Next Earnings
Aug 27, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding1,766,590,300
10 Day Avg. Volume1,266,098
30 Day Avg. Volume1,048,973
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
LBT Innovations Limited News
PremiumCompany Announcements
Clever Culture Systems Secures Instrument Sale to Novo Nordisk for Evaluation
PremiumCompany Announcements
Clever Culture Systems Unveils Updated Company Presentation
PremiumCompany Announcements
Clever Culture Systems Limited to Quote 800,000 New Securities on ASX
PremiumCompany Announcements
Clever Culture Systems Issues Unquoted Options
PremiumCompany Announcements
Clever Culture Systems Announces Proposed Securities Issue
PremiumCompany Announcements
Clever Culture Systems Reports Strong Sales Momentum and Positive CashflowPremiumCompany Announcements
Clever Culture Systems Achieves First Half-Year Profit Amid Strategic ShiftOptions Prices
Currently, No data available
---
Ownership Overview
5.70%
Insiders
―
Mutual Funds
― Other Institutional Investors
94.30% Public Companies and
Individual Investors
CC5 FAQ
What was LBT Innovations Limited’s price range in the past 12 months?
LBT Innovations Limited lowest share price was AU$0.01 and its highest was AU$0.03 in the past 12 months.
What is LBT Innovations Limited’s market cap?
LBT Innovations Limited’s market cap is AU$37.10M.
When is LBT Innovations Limited’s upcoming earnings report date?
LBT Innovations Limited’s upcoming earnings report date is Aug 27, 2025 which is in 42 days.
How were LBT Innovations Limited’s earnings last quarter?
Currently, no data Available
Is LBT Innovations Limited overvalued?
According to Wall Street analysts LBT Innovations Limited’s price is currently Overvalued.
Does LBT Innovations Limited pay dividends?
LBT Innovations Limited does not currently pay dividends.
What is LBT Innovations Limited’s EPS estimate?
LBT Innovations Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LBT Innovations Limited have?
LBT Innovations Limited has 1,766,590,300 shares outstanding.
What happened to LBT Innovations Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of LBT Innovations Limited?
Currently, no hedge funds are holding shares in AU:CC5
LBT Innovations Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:CC5 Sentiment 100%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
50.00%
12-Months-Change
Fundamentals
Return on Equity
-21.82%
Trailing 12-Months
Asset Growth
29.05%
Trailing 12-Months
Company Description
LBT Innovations Limited
LBT Innovations Ltd is a designer of advanced technology solutions for the medical industry. Its first product, MicroStreak, was a global first in the automation of the culture plate streaking process. Its second product, the Automated Plate Assessment System(APAS) is based upon LBT's intelligent imaging and machine learning software and remains the only US FDA-cleared artificial intelligence technology for automated imaging, analysis, and interpretation of microbiology culture plates following incubation.
Technical Analysis
BCAL Diagnostics Limited
―
Little Green Pharma Ltd.
―
Lumos Diagnostics Holdings Ltd.
―
Micro-X Ltd.
―
Neuroscientific Biopharmaceuticals Ltd.
―